Stay updated on Pembrolizumab for Rare Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.

Latest updates to the Pembrolizumab for Rare Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded note that publications are automatically filled from PubMed and included Revision: v3.3.2. Removed the older text stating PubMed publications are automatically created by ClinicalTrials.gov and may not be about the study.SummaryDifference0.1%

- Check28 days agoChange DetectedThe funding-status notice about potential delays due to a lapse in government funding has been removed. All study details and eligibility information remain unchanged.SummaryDifference0.3%

- Check42 days agoChange DetectedA new publication entry was added to Publications: Chahla B, Stephen B, Song J, Balderrama-Brondani V, Yaylaci F, Campbell MT, Naing A, Habra MA; Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma, J Immunother Precis Oncol. 2025 Oct 6;8(4):242-248; doi: 10.36401/JIPO-25-6; eCollection 2025 Nov.SummaryDifference0.4%

- Check71 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference2%

- Check78 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.0%

- Check92 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Rare Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.